The Path Forward: Revealing the Rare Disease Patient Journey
While each rare disease individually impacts only 200,000 people or less, with 7,000 known rare...
The therapeutic market that you know is shaped by the healthcare data that you can see. But when critical medical, specialty, clinical or longitudinal signals are absent from that view, the picture (and the decisions based on it) is less clear. ...
While each rare disease individually impacts only 200,000 people or less, with 7,000 known rare...
Today’s most innovative companies are leveraging digital health data solutions to deliver...
While it feels like we’re back to a pre-pandemic sense of normal, COVID continues to be an evolving...
With the surge in RSV cases that plagued our nation’s children at record levels this fall and over...
The challenges of the COVID-19 pandemic did bring about some positive impact, accelerating the...
Historically, clinical trial data and real-world data (RWD) have existed in silos. With increasing...
Lab Data in Clinical Research: 4 Ways It Drives Better Outcomes While most life sciences teams know...
Diabetes is a complex disease that affects over 37 million Americans, or 11% of the population, and...
As we honor our military service members this Veterans Day, we take time to reflect on how we can...
In a recent report, the Centers for Disease Control and Prevention (CDC) found that four out of...
Know what others can’t about scaling AI Artificial intelligence is already embedded in how life sciences organizations think about commercial strategy. From more precise targeting to faster insight generation and personalized engagement at scale, AI ...